The broad-spectrum antiemetic effects ETI-385 result from stimulation of 5-HT1A and 5-HT1D receptors
暂无分享,去创建一个
[1] J. Rudd,et al. Looking beyond 5-HT(3) receptors: a review of the wider role of serotonin in the pharmacology of nausea and vomiting. , 2014, European journal of pharmacology.
[2] Joanna L. Sharman,et al. IUPHAR-DB: updated database content and new features , 2012, Nucleic Acids Res..
[3] P. Kranke,et al. Intravenous buspirone for the prevention of postoperative nausea and vomiting , 2012, European Journal of Clinical Pharmacology.
[4] J. Lucot,et al. Guamanian Suncus murinus responsiveness to emetic stimuli and the antiemetic effects of 8-OH-DPAT , 2011, Pharmacology Biochemistry and Behavior.
[5] R. Naylor,et al. The effect of the 5-HT1A receptor agonist, 8-OH-DPAT, on motion-induced emesis in Suncus murinus , 2006, Pharmacology Biochemistry and Behavior.
[6] Michal Brylinski,et al. Stereoselectivity of 8-OH-DPAT toward the serotonin 5-HT1A receptor: biochemical and molecular modeling study. , 2006, Biochemical pharmacology.
[7] H. Lutsep. Repinotan, A 5-HT1A agonist, in the treatment of acute ischemic stroke. , 2005, Current Drug Targets - CNS & Neurological Disorders.
[8] Y. Gupta,et al. Involvement of 5-HT1A and 5-HT2 receptor in cisplatin induced emesis in dogs. , 2002, Indian journal of physiology and pharmacology.
[9] J. Greuel,et al. Characterization of the aminomethylchroman derivative BAY x 3702 as a highly potent 5-hydroxytryptamine1A receptor agonist. , 1998, The Journal of pharmacology and experimental therapeutics.
[10] J. Gidda,et al. Pharmacological profile of LY301317, a potent and selective 5‐HT1A agonist , 1997 .
[11] N. Matsuki,et al. Ethanol-induced emesis in the house musk shrew, Suncus murinus. , 1996, Life sciences.
[12] N. Matsuki,et al. The pharmacology of the emetic response to upper gastrointestinal tract stimulation in Suncus murinus. , 1996, European journal of pharmacology.
[13] H. Westenberg,et al. Effects of the 5-HT1A receptor agonist flesinoxan in panic disorder , 1996, Psychopharmacology.
[14] J. Leander,et al. Comparison of the antiemetic effects of a 5-HT1A agonist, LY228729, and 5-HT3 antagonists in the pigeon , 1995, Pharmacology Biochemistry and Behavior.
[15] A. Alfieri,et al. Comparative efficacy of a single oral dose of ondansetron and of buspirone against cisplatin-induced emesis in cancer patients. , 1995, British Journal of Cancer.
[16] J. Leander,et al. Antiemetic effects of 5-HT1A agonists in the pigeon , 1994, Pharmacology Biochemistry and Behavior.
[17] R. Naylor,et al. Profiles of emetic action of cisplatin in the ferret: a potential model of acute and delayed emesis. , 1994, European journal of pharmacology.
[18] J. Lucot. Antiemetic effects of flesinoxan in cats: comparisons with 8-hydroxy-2-(di-n-propylamino)tetralin. , 1994, European journal of pharmacology.
[19] D. Wong,et al. Preclinical studies on LY228729: a potent and selective serotonin1A agonist. , 1993, The Journal of pharmacology and experimental therapeutics.
[20] L. Arvidsson,et al. Intrinsic activity of enantiomers of 8-hydroxy-2-(di-n-propylamino)tetralin and its analogs at 5-hydroxytryptamine1A receptors that are negatively coupled to adenylate cyclase. , 1991, Molecular pharmacology.
[21] G. H. Crampton,et al. Habituation of motion sickness in the cat. , 1991, Aviation, space, and environmental medicine.
[22] J. Lucot. Effects of serotonin antagonists on motion sickness and its suppression by 8-OH-DPAT in cats , 1990, Pharmacology Biochemistry and Behavior.
[23] G. H. Crampton,et al. 8-OH-DPAT suppresses vomiting in the cat elicited by motion, cisplatin or xylazine , 1989, Pharmacology Biochemistry and Behavior.
[24] J. Fozard,et al. Antihypertensive effects of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) in conscious dogs. , 1988, European journal of pharmacology.
[25] G. H. Crampton,et al. Buspirone blocks motion sickness and xylazine-induced emesis in the cat. , 1987, Aviation, space, and environmental medicine.
[26] G. H. Crampton,et al. Buspirone Blocks Cisplatin‐Induced Emesis in Cats , 1987, Journal of clinical pharmacology.
[27] G. H. Crampton,et al. Xylazine emesis, yohimbine and motion sickness susceptibility in the cat. , 1986, The Journal of pharmacology and experimental therapeutics.
[28] G. H. Crampton,et al. A stimulator for laboratory studies of motion sickness in cats. , 1985, Aviation, space, and environmental medicine.
[29] H. L. Borison,et al. A new concept of organization of the central emetic mechanism: recent studies on the sites of action of apomorphine, copper sulfate and cardiac glycosides. , 1952, Gastroenterology.
[30] M. Simoons,et al. 5-Hydroxytryptamine-induced contractions of the human isolated saphenous vein: involvement of 5-HT2 and 5-HT1D-like receptors, and a comparison with grafted veins , 2004, Naunyn-Schmiedeberg's Archives of Pharmacology.
[31] N. Matsuki,et al. Antiemetic effects of serotonergic 5-HT1A-receptor agonists in Suncus murinus. , 1994, Japanese journal of pharmacology.